Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: βAcalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 studyβ.
Benjamin L. Lampson, Svitlana Tyekucheva, Zixu Wang, Jessica Lowney, Samantha Pazienza +13 more